Symptomatic therapy and rehabilitation in primary progressive multiple sclerosis

Neurology Research International

Volumn 2011, Issue , 2011, Pages

  Khan, Fary ^a   Amatya, Bhasker ^b   Turner Stokes, Lynne ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84878097875     PISSN: 20901852     EISSN: 20901860     Source Type: Journal    
DOI: 10.1155/2011/740505     Document Type: Review

References (122)

1. Programme for Neurological Diseases and Neurosciences Department of Mental Health and Substance Abuse, Atlas: Country Resources for Neurological Disorders: Results of a Collaborative Study of World Health Organization and World Federation of Neurology,WorldHealth Organization, Geneva, Switzerland, 2004.
2. N. G. Torkildsen, S. A. Lie, J. H. Aarseth, and K. M. Myhr, "Survival and cause of death in multiple sclerosis: results from a 50-year follow-up in Western Norway," Multiple Sclerosis, vol. 14, no. 9, pp. 1191-1198, 2008.
3. F. Khan, T. McPhail, C. Brand, L. Turner-Stokes, and T. Kilpatrick, "Disability profile and quality of life in multiple sclerosis in an Australian community cohort," International Journal of Rehabilitation Research, vol. 29, no. 2, pp. 87-96, 2006. (Pubitemid 44309727)
4. R. Rovaris, E. Judica, J. Sastre-Garriga et al., "Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis," Multiple Sclerosis, vol. 14, no. 4, pp. 455-466, 2008.
5. X. Montalban, "Primary progressive multiple sclerosis," Current Opinion in Neurology, vol. 18, no. 3, pp. 261-266, 2005. (Pubitemid 40813752)
6. D. Bar-Zohar, A. Agosta, D. Goldstaub, and M. Filippi, "Magnetic resonance imaging metrics and their correlation with clinical outcomes in multiple sclerosis: A review of the literature and future perspectives," Multiple Sclerosis, vol. 14, no. 6, pp. 719-727, 2008.
7. L. Ramió-Torrentà, J. Sastre-Garriga, G. T. Ingle et al., "Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: A tissue specific magnetisation transfer study," Journal of Neurology, Neurosurgery and Psychiatry, vol. 77, no. 1, pp. 40-45, 2006. (Pubitemid 43022688)
8. A. Kutzelnigg, C. F. Lucchinetti, C. Stadelmann et al., "Cortical demyelination and diffuse white matter injury in multiple sclerosis," Brain, vol. 128, no. 11, pp. 2705-2712, 2005. (Pubitemid 41552953)
9. M. Rovaris, M. Bozzali, G. Santuccio et al., "In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis," Brain, vol. 124, no. 12, pp. 2540-2549, 2001. (Pubitemid 33134941)
10. M. Bieniek, D. R. Altmann, G. R. Davies et al., "Cord atrophy separates early primary progressive and relapsing remitting multiple sclerosis," Journal of Neurology, Neurosurgery and Psychiatry, vol. 77, no. 9, pp. 1036-1039, 2006. (Pubitemid 44338524)
11. C. H. Polman, S. C. Reingold, G. Edan et al., "Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald criteria"," Annals of Neurology, vol. 58, no. 6, pp. 840-846, 2005.
12. C. H. Polman, S. C. Reingold, B. Banwell et al., "Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria," Annals of Neurology, vol. 69, no. 2, pp. 292-302, 2011.
13. N. Grytten, S. A. Torkildsen, J. H. Aarseth, H. Nyland, and K. M. Myhr, "Survival and cause of death in multiple sclerosis: results from a 50-year follow-up in Western Norway," Multiple Sclerosis, vol. 14, no. 9, pp. 1191-1198, 2008.
14. D. A. Cottrell, M. Kremen-chutzky, G. P. A. Rice et al., "The natural history of multiple sclerosis: A geographically based study. 5. The clinical features and natural history of primary progressivemultiple sclerosis," Brain, vol. 122, no. 4, pp. 625-639, 1999. (Pubitemid 29158771)
15. World Health Organization (WHO), The International Classification of Functioning, Disability and Health (ICF), World Health Organization, Geneva, Switzerland, 2001.
16. S. A. Steins, B. O'Brien, and M. Young, "The person, disablement and the process of rehabilitation," in PM& R Secrets, B. O'Young,M. Young, and S. A. Steins, Eds., pp. 1-8, Hanley & Belfus, Philadelphia, Pa, USA, 1997.
17. J. S.Wolinsky, P. A. Narayana, P. O'Connor et al., "Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational,multicenter, double-blind, placebo-controlled trial," Annals of Neurology, vol. 61, no. 1, pp. 14-24, 2007. (Pubitemid 46214240)
18. F. Khan and J. F. Pallant, "Use of the International Classification of Functioning, Disability and Health (ICF) to identify preliminary comprehensive and brief core sets for multiple sclerosis," Disability and Rehabilitation, vol. 29, no. 3, pp. 205-213, 2007. (Pubitemid 47179932)
19. F. Khan and J. F. Pallant, "Use of International Classification of Functioning, Disability and Health (ICF) to describe patient-reported disability in multiple sclerosis and identification of relevant environmental factors," Journal of Rehabilitation Medicine, vol. 39, no. 1, pp. 63-70, 2007.
20. G. H. Kraft and J. Y. Cui, "Multiple sclerosis," in Physical Medicine and Rehabilitation: Principles and Practice, J. A. Delisa, Ed., pp. 1753-1769, 4th edition, 2005.
21. D. T. Wade, Measurement in Neurological Rehabilitation, Oxford University Press, 1992.
22. J. C. Hobart, D. L. Lamping, J. A. Freeman et al., "Evidence based measurement: which disability scale for neurologic rehabilitation?" Neurology, vol. 57, no. 4, pp. 639-644, 2001. (Pubitemid 32782991)
23. D. A. Rossiter, A. Edmondson, R. Al-Shahi et al., "Integrated pathways in multiple sclerosis: completing the audit cycle," Multiple Sclerosis, vol. 4, no. 2, pp. 85-89, 1998. (Pubitemid 28197352)
24. F. Khan, J. F. Pallant, and L. Turner-Stokes, "Use of goal attainment scaling in inpatient rehabilitation for persons with multiple sclerosis," Archives of Physical Medicine and Rehabilitation, vol. 89, no. 4, pp. 652-659, 2008. (Pubitemid 351406331)
25. Royal College of Physicians, National Council for Palliative care. British Society of Rehabilitation Medicine, Concise Guidance to Good Practice Series, vol. 10, Royal College of Physicians, London, UK, 2008.
26. National Institute for Clinical Excellence [NICE], "Multiple Sclerosis: Management of multiple sclerosis in primary and secondary care. Clinical Guidelines-8," NICE, ISBN: 1842574426, 2003, http://www.nice.org. uk.
27. Department of Health, "The National Service Framework NSF for Long-term Conditions," DoH, UK, 2005.
28. A. J. Thompson, "Symptomatic management and rehabilitation in multiple sclerosis," Journal of Neurology, Neurosurgery and Psychiatry, vol. 71, no. 2, pp. 22-27, 2001.
29. F. Khan, L. Turner-Stokes, L. Ng, and T. Kilpatrick, " Multidisciplinary rehabilitation for adults with multiple sclerosis," The Cochrane Database of Systematic Reviews, no. 2, Article ID CD006036, 2007.
30. M. B. Reitberg, D. Brooks, B. M. J. Utidehaag, and G. Kwakkel, "Exercise therapy for multiple sclerosis," Cochrane Database of Systematic Review, no. 3, Article ID CD003980, 2004.
31. E. M. Steultjens, J. Dekker, L. M. Bouter, M. Cardol, J. C. van de Nes, and C. H. van den Ende, "Occupational therapy for multiple sclerosis," The Cochrane Database of Systematic Reviews, no. 3, p. CD003608, 2003.
32. N. A. Baker and L. Tickle-Degnen, "The effectiveness of physical, psychological, and functional interventions in treating clients with multiple sclerosis: A meta-analysis," American Journal of Occupational Therapy, vol. 55, no. 3, pp. 324-331, 2001. (Pubitemid 33661642)
33. P. W. Thomas, S. Thomas, C. Hillier, K. Galvin, and R. Baker, "Psychological interventions for multiple sclerosis," The Cochrane Database of Systematic Reviews, no. 1, p. CD004431, 2006.
34. F. Khan, J. F. Pallant, C. Brand, and T. J. Kilpatrick, "Effectiveness of rehabilitation intervention in persons with multiple sclerosis: A randomised controlled trial," Journal of Neurology, Neurosurgery and Psychiatry, vol. 79, no. 11, pp. 1230-1235, 2008.
35. L. Costelloe, K. O'Rourke, H. Kearneyet al., "The patient knows best: significant change in the physical component of the Multiple Sclerosis Impact Scale (MSIS-29 physical)," Journal of Neurology, Neurosurgery and Psychiatry, vol. 78, no. 8, pp. 841-844, 2007. (Pubitemid 47204589)
36. F. Khan, J. F. Pallant, N. Zhang, and L. Turner-Stokes, "Clinical practice improvement approach in multiple sclerosis: A pilot study," International Journal of Rehabilitation Research, vol. 33, no. 3, pp. 238-247, 2010.
37. L. Turner-Stokes and A. Shaw, "The Northwick Park Therapy Dependency Score (NPTDA): development, preliminary evaluation and application," A report for the Department of Health Project Grant 030/0066, Kings College, London, UK, 2006.
38. F. Khan, L. Turner-Stokes, T. Stevermuer, and F. Simmonds, "Multiple sclerosis rehabilitation outcomes: lessons learnt from an Australian casemix dataset," Multiple Sclerosis, vol. 15, no. 7, pp. 869-875, 2009.
39. Department ofHealth: long termconditions NSF Team, "The National Services Framework for Long Term Neurological Conditions," Department of Health, UK, 2005.
40. D. C. Traue and J. R. Ross, "Palliative care in non-malignant diseases," Journal of the Royal Society of Medicine, vol. 98, no. 11, pp. 503-506, 2005. (Pubitemid 41617762)
41. L. Turner-Stokes, N. Sykes, E. Silber, A. Khatri, L. Sutton, and E. Young, "From diagnosis to death: exploring the interface between neurology, rehabilitation and palliative care in managing people with long-term neurological conditions," Clinical Medicine, vol. 7, no. 2, pp. 129-136, 2007. (Pubitemid 46713722)
42. Paralysed Veterans of America, "Multiple Sclerosis Council for Clinical Practice Guidelines. Fatigue and Multiple Sclerosis. Evidence based management strategies for fatigue," in Multiple Sclerosis, Paralysed Veterans of America, 1998.
43. S. R. Schwid, M. Covington, B. M. Segal, and A.D. Goodman, "Fatigue in multiple sclerosis: current understanding and future directions," Journal of Rehabilitation Research and Development, vol. 39, no. 2, pp. 211-224, 2002. (Pubitemid 34627420)
44. J. Iriarte, G. Katsamakis, and P. de Castro, "The Fatigue Descriptive Scale (FDS): A useful tool to evaluate fatigue in multiple sclerosis," Multiple Sclerosis, vol. 5, no. 1, pp. 10-16, 1999. (Pubitemid 29092445)
45. J. D. Fisk, P. G. Ritvo, L. Ross, D. A. Haase, T. J. Marrie, and W. F. Schlech, "Measuring the functional impact of fatigue: initial validation of the fatigue impact scale," Clinical Infectious Diseases, vol. 18, supplement 1, pp. S79-S83, 1994. (Pubitemid 24023890)
46. J. E. Schwartz, L. Jandorf, and L. B. Krupp, "The measurement of fatigue: A new instrument," Journal of Psychosomatic Research, vol. 37, no. 7, pp. 753-762, 1993. (Pubitemid 23285135)
47. L. B. Krupp, N. G. LaRocca, J. Muir-Nash, and A. D. Steinberg, "The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus," Archives of Neurology, vol. 46, no. 10, pp. 1121-1123, 1989. (Pubitemid 19246303)
48. W. S.MacAllister and L. B. Krupp, "Multiple sclerosis related fatigue," PhysicalMedicine and Rehabilitation Clinics of North America, vol. 16, no. 2, pp. 483-502, 2005.
49. A. E. Miller, F. D. Lublin, and P. K. Coyle, Multiple Sclerosis in Clinical Practice, Martin Dunitz, Taylor and Francis, UK, 2003.
50. J. E. Freal, G. H. Kraft, and J. K. Coryell, "Symptomatic fatigue in multiple sclerosis," Archives of Physical Medicine and Rehabilitation, vol. 65, no. 3, pp. 135-138, 1984. (Pubitemid 14197598)
51. J. F. Kurtzke, "Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS)," Neurology, vol. 33, no. 11, pp. 1444-1452, 1983. (Pubitemid 14237132)
52. A. Solari, B. Uitedehaag, G. Guiliani et al., "Aminopridines for symptomatic treatment in multiple sclerosis," The Cochrane Database of Systematic Reviews, no. 4, Article ID CD001330, 2002.
53. F. Khan, J. F. Pallant, T. L. Shea, and M. Whishaw, "Multiple sclerosis: prevalence and factors impacting bladder and bowel function in an Australian community cohort," Disability and Rehabilitation, vol. 31, no. 19, pp. 1567-1576, 2009.
54. F. Khan, J. F. Pallant, J. I. Pallant, C. Brand, and T. J. Kilpatrick, "A randomised controlled trial: outcomes of bladder rehabilitation in persons with multiple sclerosis," Journal of Neurology, Neurosurgery and Psychiatry, vol. 81, no. 9, pp. 1033-1038, 2010.
55. M. de Sèze, A. Ruffion, P. Denys, P. A. Joseph, and B. Perrouin-Verbe, "The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines," Multiple Sclerosis, vol. 13, no. 7, pp. 915-928, 2007. (Pubitemid 351540864)
56. E. Munteis, M. Andreu, M. J. Téllez, D. Mon, A. Ois, and J. Roquer, "Anorectal dysfunction in multiple sclerosis," Multiple Sclerosis, vol. 12, no. 2, pp. 215-218, 2006.
57. F. Khan, J. F. Pallant, L. Ng, and M. Whishaw, "Sexual dysfunction in multiple sclerosis," Sexuality and Disability, vol. 29, pp. 101-111, 2011.
58. R.D. Penn, S. M. Savoy, D. Corcos et al., "Intrathecal baclofen for severe spinal spasticity," The New England Journal of Medicine, vol. 320, no. 23, pp. 1517-1521, 1989. (Pubitemid 19145803)
59. B. Ashworth, "Preliminary trial of carisoprodol in multiple sclerosis," Practitioner, vol. 192, pp. 540-542, 1964.
60. A. Haugh, A. Pandyan, and G. Johnson, "A systematic review of the Tardieu scale for the measurement of spasticity," Disability and Rehabilitation, vol. 28, no. 15, pp. 899-907, 2006. (Pubitemid 44138064)
61. A. D. Goodman, T. R. Brown, K. R. Edwards et al., "A phase 3 trial of extended release oral dalfampridine in multiple sclerosis," Annals of Neurology, vol. 68, no. 4, pp. 494-502, 2010.
62. A. D. Goodman, T. R. Brown, L. B. Krupp et al., "Sustainedrelease oral fampridine in multiple sclerosis: A randomised, double-blind, controlled trial," The Lancet, vol. 373, no. 9665, pp. 732-738, 2009.
63. L. R. Mehata, M. P. McDermott, A. D. Goodman et al., "A randomised trial of mematine as treatment for spasticity in multiple sclerosis," Multiple Sclerosis, vol. 16, no. 2, pp. 248-251, 2010.
64. I. Mohammed and A. Hussain, "Intrathecal baclofen withdrawal syndrome-a life-threatening complication of baclofen pump: A case report," BMC Clinical Pharmacology, vol. 4, no. 6, 2005.
65. N. Hyman, M. Barnes, B. Bhakta et al., "Botulinum toxin (Dysport-) treatment of hip adductor spasticity in multiple sclerosis: A prospective, randomised, double blind, placebo controlled, dose ranging study," Journal of Neurology Neurosurgery and Psychiatry, vol. 68, no. 6, pp. 707-712, 2000.
66. S. E. Lord, D. T. Wade, and P. W. Halligan, "A comparison of two physiotherapy treatment approaches to improve walking in multiple sclerosis: A pilot randomized controlled study," Clinical Rehabilitation, vol. 12, no. 6, pp. 77-86, 1998.
67. R. J. Mills, L. Yap, and C. A. Young, "Treatment for ataxia in multiple sclerosis," The Cochrane Database of Systematic Reviews, no. 1, Article ID CD005029, 2007.
68. A. Beric, "Central pain and dysesthesia syndrome," Neurologic Clinics, vol. 16, no. 4, pp. 899-918, 1998. (Pubitemid 28509794)
69. J. Boivie, "Central pain," in Textbook of Pain, P. D. Wall and R. Melzack, Eds., pp. 879-914, Churchill Livingstone, New York, NY, USA, 1999.
70. B. C. Hans, W. D. Willis, and C. E. Hulsebosch, "Temporal plasticity of dorsal horn somatosensory neurons after acute and chronic spinal cord hemisection in rat," Brain Research, vol. 970, no. 1-2, pp. 238-241, 2003. (Pubitemid 36423201)
71. D. M. Ehde, T. L. Osborne, and M. P. Jensen, "Chronic pain in persons with multiple sclerosis," Physical Medicine and Rehabilitation Clinics of North America, vol. 16, no. 2, pp. 503-512, 2005. (Pubitemid 40704681)
72. F. Khan and J. Pallant, "Multiple sclerosis: The prevalence of chronic pain-related disability and psychological factors impacting quality of life in an Australian community cohort," Journal of Pain, vol. 8, no. 8, pp. 14-23, 2007.
73. C. J. Archibald, P. J. McGrath, P. G. Ritvo et al., "Pain prevalence, severity and impact in a clinic sample of multiple sclerosis patients," Pain, vol. 58, no. 1, pp. 89-93, 1994.
74. F. Khan, J. F. Pallant, B. Amatya et al., "Cognitive-behavioral classifications of chronic pain in patients with multiple sclerosis," International Journal of Rehabilitation Research, vol. 34, no. 3, pp. 235-242, 2011.
75. A. Burke-Doe, "Pain management," in Neurological Rehabilitation, D. A. Umphred, Ed., Mosby Elsivier, St Louis, Mo, USA, 5th edition, 2007.
76. M. K. Houtchens, J. R. Richert, A. Sami, and J. W. Rose, "Open label gabapentin treatment for pain in multiple sclerosis," Multiple Sclerosis, vol. 3, no. 4, pp. 250-253, 1997. (Pubitemid 27478591)
77. J. Al Smadi, C. Campbell, L. Nicholl et al., "A pilot investigation of the hypoalgesic effects of transcutaeous electrical stimulation upon lower back in people with multiple sclerosis," Clinical Rehabilitation, vol. 17, no. 7, pp. 742-749, 2003.
78. L. Frighetto, A. A. de Salles, Z. A. Smith, B. Goss, M. Selch, and T. Solberg, "Noninvasive linear accelerator radiosurgery as the primary treatment for trigeminal neuralgia," Neurology, vol. 62, no. 4, pp. 660-662, 2004. (Pubitemid 38252818)
79. D. J. Rog, T. J. Nurmikko, T. Friede, and C. A. Young, "Randomized, controlled trial of cannabis-basedmedicine in central pain in multiple sclerosis," Neurology, vol. 65, no. 6, pp. 812-819, 2005. (Pubitemid 41362120)
80. C. Solaro, M. Boehmker, and P. Tanganelli, "Pregabalin for treating paroxysmal painful symptoms in multiple sclerosis," Journal of Neurology, vol. 256, no. 10, pp. 1773-1774, 2009.
81. P. Gray, "Pregabalin in the management of central neuropathic pain," Expert Opinion on Pharmacotherapy, vol. 8, no. 17, pp. 3037-3041, 2007.
82. R. K. Heaton, "Neoropsychologicl findings in relapsing- remitting and chronic progressivdmultiple sclerosis," Journal of Consulting and Clinical Psychology, vol. 53, no. 1, pp. 103-110, 1985. (Pubitemid 15096165)
83. S. M. Rao, G. J. Leo, L. Bernardin, and F. Unverzagt, "Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction," Neurology, vol. 41, no. 5, pp. 685-691, 1991.
84. M. Pepping and D.M. Ehde, "Neuropsychological evaluation and treatment of multiple sclerosis: The importance of a neuro-rehabilitation focus," Physical Medicine and Rehabilitation Clinics of North America, vol. 16, no. 2, pp. 411-436, 2005. (Pubitemid 40704677)
85. D. Frankel, "Multiple sclerosis," in Neurological Rehabilitation, D. A. Umphred, Ed., pp. 709-731, Mosby Elsievier, St Louis, Mo, USA, 5th edition, 2007.
86. G. M. Franklin, L. M. Nelson, C.M. Filley, and R. K. Heaton, "Cognitive loss in multiple sclerosis," Archives of Neurology, vol. 46, no. 2, pp. 162-169, 1989.
87. Y. Goverover, M. Basso, H. Wood et al., "Examining the benefits of combining two learning strategies on recall of functional information in persons with multiple sclerosis," Multiple Sclerosis. In press.
88. A. M. Plohmann, L. Kappos, W. Ammann et al., "Computer assisted retraining of attentional impairments in patients with multiple sclerosis," Journal of Neurology Neurosurgery and Psychiatry, vol. 64, no. 4, pp. 455-462, 1998. (Pubitemid 28195945)
89. M. W. Geisler, M. Sliwinski, P. K. Coyle, D. M. Masur, C. Doscher, and L. B. Krupp, "The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis," Archives of Neurology, vol. 53, no. 2, pp. 185-188, 1996. (Pubitemid 26055267)
90. A. Weinstein, S. R. Schwid, R. B. Schiffer, M. P. McDermott, D. W. Giang, and A. D. Goodman, "Neuropsychologic status in multiple sclerosis after treatment with glatiramer actetate (Copaxone)," Archives of Neurology, vol. 56, no. 3, pp. 319-324, 1999. (Pubitemid 29120229)
91. J. F. Lovera, E. Frohman, T. R. Brown et al., "Memantine for cognitive impairment in multiple sclerosis: A randomized placebo-controlled trial,"Multiple Sclerosis, vol. 16, no. 6, pp. 713-723, 2010.
92. L. B. Krupp, C. Christodoulou, P.Melville et al., "Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis," Neurology, vol. 76, no. 17, pp. 1500-1507, 2011.
93. K. Aronson, E. Goldenberg, and G. Cleghorn, "Sociodemographic characteristics and health status of persons with multiple sclerosis and their caregivers," MSManagement, vol. 3, no. 1, pp. 5-15, 1996.
94. M. Starck, H. Albrecht, W. Pöllmann, A. Straube, and M. Dieterich, "Drug therapy for acquired pendular nystagmus in multiple sclerosis," Journal of Neurology, vol. 244, no. 1, pp. 9-16, 1997. (Pubitemid 26413892)
95. R. M.Merson andM. I. Rolnick, "Speech-language pathology and dysphagia in multiple sclerosis," Physical Medicine and Rehabilitation Clinics of North America, vol. 9, no. 3, pp. 63-71, 1998.
96. S. Sapir, A. A. Pawlas, L. O. Ramig, E. Seeley, C. Fox, and J. Corboy, "Effects of intensive phonatory-respiratory treatment (LSVT) on voice in two individuals with multiple sclerosis," Journal of Medical Speech-Language Pathology, vol. 9, no. 2, pp. 141-151, 2001. (Pubitemid 32531046)
97. L. Hartelius and L. Nord, "Speech modification in dysarthria associated with multiple sclerosis: an intervention based on vocal efficiency, contrastive stress, and verbal repair strategies," Journal of Medical Speech-Language Pathology, vol. 5, no. 2, pp. 113-140, 1997. (Pubitemid 127534487)
98. F. J. Thomas and C. M. Wiles, "Dysphagia and nutritional status in multiple sclerosis," Journal of Neurology, vol. 246, no. 8, pp. 677-682, 1999. (Pubitemid 29417849)
99. P. Calcagno, G. Ruoppolo, M. G. Grasso, M. de Vincentiis, and S. Paolucci, "Dysphagia in multiple sclerosis- prevalence and prognostic factors," Acta Neurologica Scandinavica, vol. 105, no. 1, pp. 40-43, 2002. (Pubitemid 34188268)
100. A. de Pauw, E. Dejaeger, B. D'hooghe, and H. Carton, "Dysphagia in multiple sclerosis," Clinical Neurology and Neurosurgery, vol. 104, no. 4, pp. 345-351, 2002. (Pubitemid 34828293)
101. S. B. Patten, C. A. Beck, J. V. A.Williams, C. Barbui, and L.M. Metz, "Major depression in multiple sclerosis: A populationbased perspective," Neurology, vol. 61, no. 11, pp. 1524-1527, 2003. (Pubitemid 37505573)
102. W. Katon and P. Ciechanowski, "Impact of major depression on chronic medical illness," Journal of Psychosomatic Research, vol. 53, no. 4, pp. 859-863, 2002. (Pubitemid 35282614)
103. R. H. B. Benedict, J. S. Fischer, C. J. Archibald et al., "Minimal neuropsychological assessment of MS patients: A consensus approach," Clinical Neuropsychologist, vol. 16, no. 3, pp. 381-397, 2002. (Pubitemid 36390381)
104. D. C. Mohr, A. C. Boudewn, D. E. Goodin et al., "Comparative outcomes for individual cognitive behaviour therapy, supportive espressive group psychotherapy, and setraline for the treatment of depression in multiple sclerosis," Journal of Consulting and Clinical Psychology, vol. 69, no. 6, pp. 942-949, 2001. (Pubitemid 33140495)
105. D. C. Mohr, W. Likosky, A. Bertagnolli et al., " Telephoneadministered cognitive-behavioral therapy for the treatment of depressive symptoms in multiple sclerosis," Journal of Consulting and Clinical Psychology, vol. 68, no. 2, pp. 356-361, 2000.
106. A. L. Brosse, E. S. Sheets, H. S. Lett, and J. A. Blumenthal, "Exercise and the treatment of clinical depression in adults: recent findings and future directions," Sports Medicine, vol. 32, no. 12, pp. 741-760, 2002. (Pubitemid 35216536)
107. E. W. Martinsen, "Physical activity and depression: clinical experience," Acta Psychiatrica Scandinavica, vol. 377, pp. 23-27, 1994. (Pubitemid 24147800)
108. D. R. Hopko, C. W. Lejuez, K. J. Ruggiero, and G. H. Eifert, "Contemporary behavioral activation treatments for depression: procedures, principles, and progress," Clinical Psychology Review, vol. 23, no. 5, pp. 699-717, 2003. (Pubitemid 37100984)
109. G. L. Klerman and M. M. Weissmann, "Interpersonal psychotherapy (IPT) and drugs in the treatment of depression," Pharmacopsychiatry, vol. 20, no. 1, pp. 3-7, 1987. (Pubitemid 17227978)
110. F. Khan, J. Pallant, and C. Brand, "Caregiver strain and factors associated with caregiver self-efficacy and quality of life in a community cohort withmultiple sclerosis," Disability and Rehabilitation, vol. 29, no. 16, pp. 1241-1260, 2007.
111. R. H. B. Benedict, A. Shapiro, R. Priore, C. Miller, F. Munschauer, and L. Jacobs, "Neuropsychological counseling improves social behavior in cognitively-impaired multiple sclerosis patients," Multiple Sclerosis, vol. 6, no. 6, pp. 391-396, 2000. (Pubitemid 32106800)
112. T. R. Brown and G. H. Kraft, "Exercise and rehabilitation for individuals withmultiple sclerosis," PhysicalMedicine and Rehabilitation Clinics of North America, vol. 16, no. 2, pp. 513-556, 2005.
113. A. T.White, "Exercise and MS: challenges and opportunities," Multiple Sclerosis Quality Report, vol. 23, no. 1, pp. 18-20, 2004.
114. D. C. Hewson, M. A. Phillips, K. E. Simpson, P. Drury, and M. A. Crawford, "Food intake in multiple sclerosis," Human Nutrition. Applied nutrition, vol. 38, no. 5, pp. 355-367, 1984.
115. G. H. Kraft, "Foreword," PhysicalMedicine and Rehabilitation Clinics of North America, vol. 9, no. 3, pp. 11-13, 1998.
116. M. L. Aisen, A. Arnold, I. Baiges, S. Maxwell, and M. Rosen, "The effect of mechanical damping loads on disabling action tremor," Neurology, vol. 43, no. 7, pp. 1346-1350, 1993. (Pubitemid 23213807)
117. M. M. LaBan, T.Martin, J. Pechur, and S. Sarnacki, "Physical and occupational therapy in the treatment of patients with multiple sclerosis," Physical Medicine and Rehabilitation Clinics of North America, vol. 9, no. 3, pp. 603-614, 1998. (Pubitemid 28405508)
118. H. Bronnum-Hansen, H. Hansen, N. Kock-Henriksen, and E. Stenager, "Fatal accidents among Danes with multiple sclerosis," Multiple Sclerosis, vol. 12, pp. 329-332, 2006. (Pubitemid 43827189)
119. M. T. Schulthesis, E. Garay, S. R. Millis, and J. DeLuca, "Motor vehicle crashes and violations among drivers with multiple sclerosis," Archives of Physical Medicine and Rehabilitation, vol. 83, no. 8, pp. 1175-1178, 2002. (Pubitemid 34832950)
120. P. Rumrill, Employment Issues and Multiple Sclerosis, Demos Publications, New York, NY, USA, 1996.
121. K. L. Johnson and R. T. Fraser, "Mitigating the impact of multiple sclerosis on employment," Physical Medicine and Rehabilitation Clinics of North America, vol. 16, no. 2, pp. 771-783, 2005.
122. F. Khan, L. Ng, and L. Turner-Stokes, "Effectiveness of vocational rehabilitation intervention on the return to work and employment of persons with multiple sclerosis," The Cochrane Database of Systematic Reviews, no. 1, Article ID CD007256, 2009.